DIMENSIONAL FUND ADVISORS LP

Position in IPSC — Century Therapeutics, Inc.

CIK 354204 AUSTIN, TX

Position in IPSC

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$665,153

+$540,442 QoQ

Shares Held

271,492

+392.0% QoQ

Ownership

0.150%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#34

of 98 holders

Holding Since

Sep 2022

13 quarters on record

Voting authority Sole 79% Shared 18% None 3%

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $6,105,781,868 across 230 Biotechnology names. IPSC ranks #173 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,168,956	$580,655,511
2	JAZZ	Jazz Pharmaceuticals plc	1,713,592	$412,924,262
3	REGN	Regeneron Pharmaceuticals, Inc.	559,687	$348,987,230
4	INCY	Incyte Corp	2,280,803	$258,551,825
5	EXEL	Exelixis, Inc.	4,426,620	$240,852,392
6	BMRN	Biomarin Pharmaceutical Inc	4,075,714	$233,212,353
7	ROIV	Roivant Sciences Ltd.	5,230,417	$185,104,455
8	KRYS	Krystal Biotech, Inc.	476,038	$176,929,041

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$665,153	271,492	+392.0%	Shares	Sole	2026-08-11
2026-03-31	$124,711	55,183	+106.4%	Shares	Sole	2026-05-07
2025-03-31	$12,724	26,735	-0.5%	Shares	Sole	2025-05-13
2024-12-31	$27,142	26,874	-19.7%	Shares	Sole	2025-02-13
2024-09-30	$57,197	33,449	-55.6%	Shares	Sole	2024-11-07
2024-06-30	$192,052	75,315	+141.7%	Shares	Sole	2024-08-09
2024-03-31	$130,248	31,160	-4.4%	Shares	Sole	2024-05-10
2023-12-31	$108,225	32,598	+16.3%	Shares	Sole	2024-02-07
2023-09-30	$56,052	28,026	-8.1%	Shares	Sole	2023-11-09
2023-06-30	$96,350	30,491	-22.7%	Shares	Sole	2023-08-09
2023-03-31	$136,901	39,453	-38.7%	Shares	Sole	2023-05-12
2022-12-31	$329,910	64,310	+71.8%	Shares	Sole	2023-02-09
2022-09-30	$370,281	37,440	—	Shares	Sole	2022-11-10
No filing history on record for this holder in this stock.